拉布多米索尔科马:当前的治疗方法,挑战和未来的治疗策略方法
Ali Zarrabi1, David Perrin2, Mahboubeh Kavoosi3,4
1Department of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Istinye University, Sariyer, Istanbul 34396, Türkiye.
Cancers
|November 14, 2023
概括
罕见的儿童肌肉癌 - - 拉布多米索尔科马 (rhabdomyosarcoma) 提出了治疗挑战,特别是在转移性和复发性病例中. 本综述详细介绍了其临床方面,化疗和新型治疗查模型.
科学领域:
- 儿科瘤学 儿科瘤学
- 癌症生物学 癌症生物学
- 肌肉再生 肌肉再生
背景情况:
- 狂肌肉瘤是一种罕见的骨肌癌,主要影响儿童和年轻人.
- 转移性和复发性狂宫肌肉瘤在儿科瘤学中存在重大挑战.
- 目前的治疗包括手术,化疗和放射治疗,正在进行改善结果的研究.
研究的目的:
- 为了提供一个全面的临床概述rhabdomyosarcoma,包括分类,诊断和治疗.
- 分析化疗策略及其对细胞机制的影响,如细胞亡,宏自,并在rhabdomyosarcoma中展开蛋白质反应.
- 探索体内和体外模型的实用性,以选未来的狂宫肌肉瘤疗法,并促进肌肉再生.
主要方法:
- 在文学上对拉布多米索尔科马的分类,诊断和治疗策略进行了综述.
- 化学疗法机制的分析,包括亡,宏自和未折叠的蛋白质反应.
- 对已建立和新兴的临床前模型 (老鼠,斑马鱼,3D生物工程) 进行骨髓瘤研究的审查.
主要成果:
- 轮骨髓瘤需要多模式治疗,但晚期疾病的结果仍然很差.
- 化疗反应受到亡,宏自和展开的蛋白质反应途径的影响.
- 临床前模型为评估新型治疗剂和再生策略提供了有价值的平台.
结论:
- 彻底了解rhabdomyosarcoma的临床和生物方面对于推进治疗至关重要.
- 准参与化疗反应的关键细胞机制可能会提高治疗疗效.
- 创新的临床前模型对于开发下一代疗法和解决拉布地肌肉肉瘤幸存者的肌肉再生至关重要.
相关概念视频
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533
01:19Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K